• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Pankaj Jain, PhD, MBA, PgMP

Latest:

Value Realization: An Unattained Challenge for Integrated Practice Units

As value realization eludes integrated practice units (IPUs), the authors examine 6 key value drivers for IPU teams to competitively drive volumes and hone their multidisciplinary competencies.


Steven Levine, MD

Latest:

Optimizing the Management of TRD

Drs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.


Scott Sibbel, PhD, MPH

Latest:

Predicting Hospitalizations for Patients With Chronic Kidney Disease

The authors developed an algorithm that uses medical claims to identify patients with chronic kidney disease who are at greatest risk of being hospitalized within 90 days.


Caroline J. Alper, MD

Latest:

Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid Population

The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan.


Robert Weech-Maldonado, PhD

Latest:

Medicare Advantage Customer Service Is Used Most by Higher-Need Patients

Medicare Advantage customer service supports a less healthy, higher-need population, indicating that it should be designed and staffed to effectively serve complex, high-need patients.


Nora V. Becker, MD, PhD

Latest:

Out-of-Pocket Spending for Health Care After COVID-19 Hospitalization

For most patients who survive COVID-19 hospitalization, out-of-pocket spending within 180 days of discharge is modest. However, 1 in 10 have out-of-pocket spending exceeding $2000.



Paul Skluzacek, MD

Latest:

Dallas Nephrology Associates’ Journey to Value-Based Care

Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach, Dallas Nephrology Associates has demonstrated improved patient outcomes and value for payers.


Dr Gerard Criner
Gerard Criner, MD, FACP, FACCP

Latest:

FDA Approval of Mepolizumab Offers New Hope for Patients With Eosinophilic COPD: Gerard Criner, MD, FACP, FACCP

Gerard Criner, MD, FACP, FACCP, MATINEE investigator, highlights trial results that showed reduced exacerbations and delayed disease progression in patients with eosinophilic chronic obstructive pulmonary disease (COPD).


Rena Conti, PhD

Latest:

Association of 340B Contract Pharmacy Growth With County-Level Characteristics

The growth of 340B contract pharmacies since 2010 is unprecedented. This study’s findings suggest that patterns of growth differ between safety-net clinics and hospitals.


Jack Tsai, PhD, MSCP

Latest:

Research Will Be Integral in Evaluating the Efficacy of Executive Order Regarding Homelessness: Jack Tsai, PhD, MSCP

Jack Tsai, PhD, MSCP, emphasized that comparing the methods of different jurisdictions can aid decision-making as the new executive order is enacted.


Reza Amini, PhD, MD, MPH

Latest:

Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities

This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.


Vivek Bhalla, MD | Image Credit: © Stanford University School of Medicine
Vivek Bhalla, MD

Latest:

Overcoming Barriers to Detect Primary Aldosteronism: Vivek Bhalla, MD

Primary aldosteronism is often overlooked in hypertension. Educating providers and utilizing tools can enhance screening and treatment effectiveness, emphasizes Vivek Bhalla, MD, Stanford.


Virginia Wang, PhD

Latest:

Have Racial Disparities in Home Dialysis Utilization Changed Over Time?

Medicare prospective payment for dialysis modestly increased availability and use of home-based dialysis treatment but did not affect historic racial disparities in home dialysis.


Jessica A. Davila, PhD, MS

Latest:

Care Transitions: Opportunities to Better Serve the Traveling Patient

The authors share a model that facilitates patient-centered care and can be adopted by other health systems to encourage successful care transitions for the traveling patient.


Rahul Chaudhary, MD, MBA

Latest:

COVID-19 and Clinic Workflow Optimization Using Lean Six Sigma

The authors report an approach of outpatient clinic workflow reorganization utilizing simple, inexpensive measures to improve patient engagement and experience in addition to providing a safe setting for patients for clinic visits in the wake of COVID-19.


Denise Giambalvo, MBA, vice president for the Midwest Business Group on Health (MBGH)
Denise Giambalvo, MBA

Latest:

Contributor: Companies Can’t Afford a She-cession

As working women have been disproportionately impacted by COVID-19, solutions to address what has been coined a “she-cession” include targeted communications, flexible work schedules, and increased education/tutoring resources.


Sara Khor, MASc

Latest:

Factors Associated With Lung Cancer Risk Factor Documentation

This cross-sectional observational study found several factors associated with whether a patient had sufficient lung cancer risk factor documentation in the electronic health record.


Sikander Ailawadhi, MD

Latest:

Advancing Hematologic Care and the Future of Shared Decision-Making

Sikander Ailawadhi, MD, discusses how the studies presented at ASH 2024 highlight significant unmet needs in hematologic cancer management, emphasizing the potential for these findings to influence future clinical practices and shared decision-making models, while identifying key areas for further research and collaboration to improve patient outcomes.


Milam Ford, MPH, MBA, BSPharm

Latest:

Association of Co-pay Elimination With Medication Adherence and Total Cost

This study evaluated cost and utilization attributed to members enrolled in a health care program with no pharmacy co-pay. Health care savings were identified in addition to medication adherence improvements.


Long Vu, MS

Latest:

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.



Kyan C. Safavi, MD, MBA

Latest:

Potential Impact of Hospital at Home on Postoperative Readmissions

Many postoperative readmissions are amenable to diversion to a hospital at home program for surgical patients, representing an opportunity to generate revenue and improve patient experience.


James Froehlich, MD, MPH

Latest:

Diagnosis Patterns and Stress Testing Trends After Implementing High-Sensitivity Troponin Assay

This study found that switching from a conventional troponin assay to a high-sensitivity troponin assay resulted in changes to diagnosis patterns and stress testing trends.


William Wulf, MD

Latest:

Managing Total Knee Replacement Under Value-Based Payments

This article describes the approach that a large primary care group at risk for value-based payments chose to deploy in managing clinical and financial outcomes of knee osteoarthritis jointly with orthopedic surgeons.


Shiven Bhardwaj, PharmD, MAS

Latest:

Implementation and Cost Validation of a Real-time Benefit Tool

This study evaluates impact of a real-time benefit tool on medication access and physician and pharmacy workflows at a large academic medical center.


Wendy Wolfersteig, PhD

Latest:

Implementation of the Accountable Health Communities Model in Arizona

The Accountable Health Communities Model facilitates multisector coordination. Implementation science elucidated the contextual factors that facilitated the use of this model in Arizona.


Kenneth Bender, PharmD, MA

Latest:

HIV-Infected Infants Treated Within Hours of Birth Attain, Sustain Undetectable Virus

Infants with HIV could be spared from requiring lifetime antiretroviral (ART) if treated within hours of birth to disrupt formation of HIV viral reservoirs.



Aakash Desai, MBBS, MPH

Latest:

Neulasta Onpro: A Coup de Grâce?

With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.